Land: Vereinigtes Königreich
Sprache: Englisch
Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sodium citrate
Teva UK Ltd
Sodium citrate
4gram
Granules for oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 07040300; GTIN: 5012617020420
Important information about Cymalon • This medicine is used to relieve the symptoms of cystitis. • It can be taken by adult females only. • Dissolve the granules in water before swallowing. Do not take • If you are a man or child. • If you are pregnant. See section 2. Talk to your doctor • If you still have symptoms after 4 days or if you get frequent symptoms. See section 2. Now read the rest of the leaflet before you use this medicine. It includes other information which might be especially important for you. • Keep this leaflet. Your may need to read it again. • Ask your pharmacist if you need any more information or advice. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 1. What the medicine is for Cymalon sachets contain granules to dissolve in water. They treat the symptoms of cystitis in women. Cystitis is an inflammation of the bladder which may be caused by an infection. This causes stinging and burning pain when you pass water. The ingredients in Cymalon make the urine lass acid and help reduce the stinging and burning sensation. 2. Before you use this medicine Do not use the medicine if you have • An allergy to citric acid (anhydrous), sodium citrate, sodium carbonate, sodium bicarbonate or any of the ingredients listed in section 6. • Heart disease. • High blood pressure. • Kidney problems. • A salt restriction in your diet. • Or are pregnant. • Men and children should not use this medicine. Cystitis is much less common in men and children. Talk to your doctor if you are a man or child with cystitis-like symptoms. The doctor will advise you on appropriate medicine for your treatment. Talk to your doctor if you have • Symptoms which carry on for more than 4 days after you start taking Cymalon. • Symptoms which keep recurring. Talk to your doctor or pharmacist if you are taking • Lithium for manic depression. • Methenamine (previously called hexamine) for urinary infect Lesen Sie das vollständige Dokument
CYMALON Summary of Product Characteristics Updated 25-Apr-2017 | Actavis UK Ltd 1. Name of the medicinal product Cymalon Lemon flavour Granules for Oral Solution 2. Qualitative and quantitative composition Each sachet of 6.76g of granules contain the following actives: Citric Acid (anhydrous) EP 1063.00mg Sodium Citrate dihydrate EP 2819.00mg Sodium Carbonate EP 130.00mg Sodium Bicarbonate EP 1200.00mg Excipients: Each sachet contains 1.5g of sucrose. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Granules for Oral Solution. 4. Clinical particulars 4.1 Therapeutic indications Cymalon Granules is indicated for the relief of symptoms due to cystitis in adult females only. 4.2 Posology and method of administration Route of administration: Oral Adults One sachet to be taken in water, three times a day over 48 hours. Children Cymalon Granules is not recommended for children. 4.3 Contraindications Cymalon Granules should not be taken in cases of pregnancy, heart disease, high blood pressure, any form of kidney disease or whenever a restricted salt intake is indicated. 4.4 Special warnings and precautions for use Patients should be advised against repeated use. If symptoms persist 48 hours after treatment is completed you are advised to consult your doctor. Do not exceed the stated dose. Keep out of the reach of children. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine. This medicinal product contains 136.5mmol (or 3.14g) sodium per maximum daily dose (3 sachets). To be taken into consideration by patients on a controlled sodium diet. 4.5 Interaction with other medicinal products and other forms of interaction Sodium containing preparations should be avoided by patients on lithium because sodium is preferentially absorbed by the kidney resulting in increased lithium excretion and reduced plasma levels. Urinary alkalinisers should not be used with hexamine because it is only effectiv Lesen Sie das vollständige Dokument